SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

Testicle Crypto is trending due to its provocative name, sparking widespread shock, amusement, and debate within the crypto community. Many are calling it a "joke" or a "pump and dump" scam, while others are making light of its rapid rise alongside similarly themed meme coins like $BALLSACK and $COCK. The discussion reflects a broader sentiment about the speculative and often absurd nature of the current meme coin market.

Alchemy Pay

Alchemy Pay (ACH) is seeing increased attention following its integration with Ripple's RLUSD stablecoin, significantly expanding its global fiat on-ramp capabilities. Further fueling community discussion are reports of Alchemy Pay securing its tenth U.S. Money-Transmitter License and a whitepaper outlining its shift towards a stablecoin-focused Layer1 blockchain, driving optimism for its compliant, enterprise-grade payment solutions and potential for future growth.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

Vor Biopharma is trending following major analyst endorsements, including an "Overweight" rating and a substantial price target from JPMorgan, coupled with a "Buy" rating from TD Cowen. The community is actively debating the significant upside potential, fueled by its lead autoimmune drug's recent Phase 3 clinical success and strategic financing, while also acknowledging its characteristic volatility.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins (PENGU) is trending amid discussions of its ambitious brand integrations, including high-profile partnerships with the NHL and Carebears, and mainstream visibility through a Las Vegas Sphere campaign. While these efforts highlight its iconic IP's expansion beyond crypto, the community remains divided with some expressing frustration over price volatility and accusations of manipulation, while others see long-term potential fueled by real-world revenue from toys and rumored ETF catalysts.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is actively trending amidst its strategic plan to separate into two independent entities by mid-2026, a move polarizing investors who are also debating recent analyst reports. Many perceive the company as a deeply undervalued defensive play with a notable dividend yield, anticipating significant value creation as market sentiment shifts towards staples. However, a skeptical contingent questions long-term growth and the separation's efficacy in addressing competitive headwinds.

Story is a purpose-built layer 1 blockchain designed specifically to onramp intellectual property (IP) to the blockchain and make it programmable.  Story tokenizes any type of IP; whether that’s an idea, an image, a real world asset, a song, an AI model, an NFT or anything in-between. By embedding usage terms, attribution, and royalty agreements directly into the blockchain, Story provides a transparent, decentralized solution for IP management. This enables IP holders to protect their work, collaborate on IP seamlessly, and unlock revenue opportunities in an AI-powered economy.

Story Protocol

Story Protocol ($IP) is generating significant buzz following its launch of on-chain prediction markets, a privacy upgrade, and new IP Portal features, driving notable token price momentum. The community is actively discussing its potential as a "sleeping giant" within the surging AI and Real World Assets (RWA) sectors, positioning it as a key player in tokenizing intellectual property. Many anticipate substantial future growth and are closely watching its ecosystem developments.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending due to heightened speculation surrounding an imminent buyout, particularly from Nestl, fueled by its limited cash runway and recent scientific publications validating its microbiome platform. While long-term investors express deep frustration over management's perceived lack of transparency, the community remains actively engaged in discussions about a potential acquisition or significant partnership.

Digital Brands Group, Inc. engages in the manufacture and sale of apparel. Its portfolio brands include Bailey 44, DSTLD, Harper and Jones, Stateside, and Sundry. The company was founded by Corey Epstein, Mark T. Lynn, and Kevin Morris on September 17, 2012 and is headquartered in Austin, TX.

Digital Brands Group Inc

Digital Brands Group is experiencing extreme volatility as it grapples with a delisting notice from NASDAQ, leading to sharp price movements. Community sentiment is deeply split between those anticipating a short squeeze and further runs, and those warning of a "scam" due to a history of reverse splits and significant dilution. The ongoing debate highlights the highly speculative nature of this micro-cap stock amid accusations of manipulative practices and concerns over its capital structure.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending with significant investor attention driven by its strategic partnership with World Liberty Financial for USD1 payroll and card integration, alongside anticipation for its upcoming SuperApp launch. The community is buzzing about ZBCN's robust real-world utility in payment streams, its favorable tokenomics with decreasing dilution risk, and its growing compliance profile, positioning it as a strong contender in the real-world asset (RWA) sector.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as investors anticipate its upcoming Q3 earnings report, with widespread analyst upgrades and a new $20 billion stock buyback fueling optimism. The community is actively discussing the company's strong financial prospects and strategic moves into private markets, though some users express frustration over recent platform issues and trade restrictions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MDxHealth SA (NASDAQ:MDXH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

MDxHealth SA (NASDAQ:MDXH - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five analysts that are currently covering the firm, MarketBeat.com reports. One...

MDxHealth SA (NASDAQ:MDXH) Short Interest Update

MDxHealth SA (NASDAQ:MDXH - Get Free Report) saw a significant drop in short interest in December. As of December 15th, there was short interest totaling 15,027 shares, a drop of 42.6% from the...

BTIG Research Reaffirms "Buy" Rating for MDxHealth (NASDAQ:MDXH)

BTIG Research restated a "buy" rating and issued a $7.00 target price on shares of MDxHealth in a research note on Tuesday...

MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of MDxHealth SA (NASDAQ:MDXH - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five ratings firms that are currently covering the company, MarketBeat Ratings...

Samjo Management LLC Sells 96,718 Shares of MDxHealth SA $MDXH

Samjo Management LLC reduced its stake in shares of MDxHealth SA (NASDAQ:MDXH - Free Report) by 5.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...

123,546 Shares in MDxHealth SA $MDXH Purchased by FreeGulliver LLC

FreeGulliver LLC purchased a new stake in MDxHealth SA (NASDAQ:MDXH - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor...

FY2025 EPS Estimates for MDxHealth Reduced by William Blair

MDxHealth SA (NASDAQ:MDXH - Free Report) - Investment analysts at William Blair reduced their FY2025 earnings estimates for shares of MDxHealth in a research report issued to clients and investors on...

MDxHealth SA (NASDAQ:MDXH) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of MDxHealth SA (NASDAQ:MDXH - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five research firms that are currently covering the company, MarketBeat.com...

TD Cowen Raises MDxHealth (NASDAQ:MDXH) Price Target to $7.00

TD Cowen raised their price objective on MDxHealth from $5.00 to $7.00 and gave the stock a "buy" rating in a report on Thursday...

MDxHealth (NASDAQ:MDXH) Price Target Raised to $9.00

Lake Street Capital raised their target price on shares of MDxHealth from $7.00 to $9.00 and gave the stock a "buy" rating in a report on Thursday...

MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.

MDXH
MDxHealth SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MDXH News

MDXHMDxHealth SA